| Zafgen is a biopharmaceutical company that has utilized its proprietary methionine aminopeptidase 2, or MetAP2, biology platform to develop the study of MetAP2 inhibitors in both common and rare metabolic disorders. We show 25 historical shares outstanding datapoints in our coverage of ZFGN's shares outstanding history.|
Understanding the changing numbers of ZFGN shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like ZFGN versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching ZFGN by allowing them to research ZFGN shares outstanding history
as well as any other stock in our coverage universe.